Wave Life Sciences (WVE) Research Hub

Wave Life Sciences (WVE) trades on NASDAQ, SG in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 3.21 USD (+0.94%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -5.42, market cap 1.09B. This hub links to the full technical, earnings and options research available for WVE.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, SG
Last close3.21 USD (+0.94%)
52-week range3.04 USD – 6.48 USD
Trend regimeRange
14-day RSI37 (Bearish)
Trailing P/E-5.42
Market cap1.09B
Dividend yield0.00%
Next earnings2026-07-30

Available research for WVE

Earnings

WVE earnings date and last-quarter result: next report 2026-07-30, last quarter miss, P/E -5.42. Updated 2026-07-23.

Options: Covered Call

Covered Call on WVE: how it works, illustrative setup around the real 3.21 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on WVE: how it works, illustrative setup around the real 3.21 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on WVE: how it works, illustrative setup around the real 3.21 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

WVE technical analysis: range, last 3.21 USD, RSI 37, 52w range 3.04 USD–6.48 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is WVE in?

Wave Life Sciences (WVE) is classified under Healthcare (Biotechnology), listed on NASDAQ, SG.

Is WVE in an uptrend or downtrend?

As of 2026-10-26, WVE is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is WVE's trailing P/E ratio?

WVE's trailing P/E is -5.42, with a market cap of 1.09B. See the earnings research page for full valuation detail.

When does WVE next report earnings?

WVE is next scheduled to report earnings on 2026-07-30.